Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06903975 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

BoTox Into the Sternocleidomastoid Muscles (SCM)

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 6 months later Aug 2026 → Mar 2027
See other at-risk trials from Boston Medical Center

Record History

  1. Primary and study completion pushed from Aug 2026 to Mar 2027v5
  2. Primary and study completion dates: Mar 2026 to Aug 2026
    • Site contact updated
    v4
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of May 2025 to May 14, 2025
    • Site details revised
    v3
  4. Re-verified, no change to tracked fieldsv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Botulinum toxin injections have been used both in the face and neck for many years. However, injection into the sternocleidomastoid muscle (SCM) has only been done to treat neck spasms. In this study botulinum toxin will be injected into the SCM to determine if this will result in a temporary slimming effect on the neck and produce a more feminine, youthful neck contour.
Trial Details
NCT Number NCT06903975
Lead Sponsor Boston Medical Center
Collaborators: Evolus, Inc.
Conditions
(from sponsor)		 Neck Muscle Issue
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov